Trial intelligence / Profile preview

ABT-712 vs Placebo in Acute Pain After Third Molar Extraction

NCT00935311Phase 2Completed

Sponsor
AbbVie Inc.
Start
Jun 2009
Primary completion
Aug 2009
Modality
Small Molecules
Countries
1
01

Overview

Phase 2, randomised, single-blind trial of hydrocodone + acetaminophen in acute pain (3 arms), sponsored by AbbVie Inc. Primary endpoint: Sum of Pain Intensity Difference at 12 hours. Started Jun 2009; status: completed.

02

Drugs

hydrocodone + acetaminophen
03

Conditions

acute pain

Beyond the preview

Go deeper on NCT00935311.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00935311.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call